GSA Capital Partners »

BioCryst Pharmaceuticals shares owned by GSA Capital Partners

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2011-12-31 $28k 11k 2.50

More positions owned by GSA Capital Partners

Amazon (AMZN)
CRH Ord (CRH)
Remitly Global (RELY)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Aon Shs Cl A (AON)
Magnite Ord (MGNI)
Zillow Group Cl A (ZG)
UnitedHealth (UNH)
Sprott Fds Tr Uranium Miners E (URNM)
Vanguard World Fds Health Car Etf (VHT)
Sba Communications Corp Cl A (SBAC)
Calavo Growers (CVGW)
Appfolio Com Cl A (APPF)
Star Bulk Carriers Corp. Shs Par (SBLK)
Bwx Technologies (BWXT)

View all positions for GSA Capital Partners

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Braidwell
Kynam Capital Management
Deerfield Management Company
Fisher Investments
Two Sigma Investments
Jennifer Ranahan
Two Sigma Advisers
Millennium Management
Norges Bank Investment Management
Rice Hall James & Associates
Balyasny Asset Management
Stifel Financial

View all funds holding BioCryst Pharmaceuticals